Drug Points
BJM 327:905, Hadjikoutis,S.,et al, 2003
Sensorineural Hearing Loss: A Reversible Effect of Vigabatrin
Neurol 61:1020-1021, Papdeas,E.,et al, 2003
Hemispherectomy for Intractable Unihemispheric Epilepsy
Neurol 61:887-890, Kossoff,E.H.,et al, 2003
Acute Myopia and Angle-Closure Glaucoma Induced by Topiramate
Neurol 61:1306, Boentert,M.,et al, 2003
Seizure Exacerbation Associated with Oxcarbazepine in Idiopathic Focal Epilepsy of Childhood
Neurol 61:1012-1013, Chapman,K.,et al, 2003
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
NEJM 349:2023-2033, Colao,A.,et al, 2003
Idiopathic Generalized Epilepsy and Choice of Antiepileptic Drugs
Neurol 61:1793-1795, Benbadis,S.R.,et al, 2003
Treatment Options for Trigeminal Neuralgia
BMJ 327:1360-1361, Merrison,A.F.A.,et al, 2003
Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial
Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003
Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003
Intrathecal Baclofen Withdrawal Mimicking Sepsis
J Emerg Med 24:423-427, Kao,L.W.,e tal, 2003
Acute Mycoplasma Pneumoniae Infection Presenting as Cholestatic Hepatitis
J Clin Microbiol 41:514-515, Grullich, C.,et al, 2003
Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome
NEJM 348:33-40, Hayflick,S.J.,et al, 2003
Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003
Agitation by Sedation
Lancet 361:308, Tuohy,K.A.,et al, 2003
Practice Parameter: Antiepileptic Drug Prophylaxis in Severe Traumatic Brain Injury
Neurol 60:10-16, Chang,B.S. &Lowenstein,D.H., 2003
Zonisamide-Induced Restless Legs Syndrome
Neurol 60:147, Chen,J.T.,et al, 2003
The Use of Topiramate in Refractory Status Epilepticus
Neurol 60:332-334, Towne,A.R.,et al, 2003
Practice Parameter: Treatment of the Child with a First Unprovoked Seizure
Neurol 60:166-175, Hirtz,D.,et al, 2003
Misdiagnosis of Epilepsy in Patients Prescribed Anticonvulsant Drugs for Other Reasons
BMJ 326:326-327, Oto,M.,et al, 2003
Rasmussen's Encephalitis
Neurol 60:422-425, Granata,T.,et al, 2003
Practice Parameter: Temporal Lobe and Localized Neocortical Resections for Epilepsy
Neurol 60:538-547, Engel,J.,et al, 2003
Intranasal Sumatriptan in Cluster Headache
Neurol 60:630-633, van Vliet,J.A.,et al, 2003
Major Malformations in Offspring of Women with Epilepsy
Neurol 60:575-579, Kaaja,E.,et al, 2003
Peri-ictal Water Drinking Lateralizes Seizure Onset to the Nondominant Temporal Lobe
Neurol 60:873-876, Trinka,E.,et al, 2003
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003
Insights Into the Diagnosis and Treatment of Lysosomal Storage Diseases
Arch Neurol 60:322-328, Wegner,D.A.,et al, 2003
Poststroke Seizures
Arch Neurol 59:195-202, Silverman,I.E.,et al, 2002
Refractory Status Epilepticus
Arch Neurol 59:205-210,188, Mayer,S.A.,et al, 2002
Chronic Diarrhea Associated with Vagal Nerve Stimulation
Neurol 58:330, Sanossian,N. &Haut,S., 2002
The PROGRESS Trial: Preventing Strokes by Lowering Blood Pressure in Patients With Cerebral Ischemia
Stroke 33:319-320, van Gijn,J., 2002
Subtherapeutic Free Phenytoin Levels Following Fosphenytoin Therapy in Status Epilepticus
Neurol 58:147-148, Koul,R. &Deleu,D., 2002
Discontinuing Antiepileptic Drugs in Patients who are Seizure Free on Monotherapy
JNNP 72:22-25,5, Specchio,L.M.,et al, 2002
The Risk-Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Genseng, Echinacea, Saw Palmetto, and Kava
Ann Int Med 136:42-53, Ernst,E., 2002
Almotriptan (AXERT) and Frovatriptan (FROVA) for Migraine
The Medical Letter 44:19-20, , 2002
The Safety of Triptans in the Treatment of Patients with Migraine
Am J Med 112:135-140, Jamieson,D.G., 2002
Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy
Stroke 33:862-875, Gorelick,P.B., 2002
The Neurological Masquerade of Intravascular Lymphomatosis
Arch Neurol 59:439-443, Beristain,X.&Azzarelli,B., 2002
Therapy for the Epilepsies
Arch Neurol 59:732-735, Van Ness,P.C., 2002
Antiepileptic Drug-Induced Bone Loss in Young Male Patients Who Have Seizures
Arch Neurol 59:781-786, Andress,D.L.,et al, 2002
Effect of Antiepileptic Drugs on Bone Density in Ambulatory Patients
Neurol 58:1348-1353, Farhat,G.,et al, 2002
Alzheimer Disease
JAMA 287:2335-2338, Cummings,J.L. &Cole,G., 2002
A New Antiepileptic Drug
JNNP 72:426-429, Shorvon,S.D. &van Rijckevorsel,K., 2002
SUNCT Syndrome: Prolonged Attacks, Refractoriness and Response to Topiramate
Neurol 58:1307, Matharu,M.S.,et al, 2002
Cholinergic Vesicular Transporters in Progressive Supranuclesar Palsy
Neurol 58:1013-1018,997, Suzuki,M.,et al, 2002
Use of Ramipril in Preventing Stroke: Double Blind Randomised Trial
BMJ 324:699-702,687, Bosch,J.,et al, 2002
Responding to Medical Events During Commercial Airline Flights
NEJM 346:1067-1073, Gendreau,M.A. &DeJohn,C., 2002
Evolving Treatment Strategies for Epilepsy
JAMA 287:2917-2920, Diaz-Arrastia,R.,et al, 2002
Intranasal Civamide For the Treatment of Episodic Cluster Headaches
Arch Neurol 59:990-994, Saper,J.R.,et al, 2002
Is There a Neurologist on the Flight?
Neurol 58:1739-1744,1717, Sirven,J.I.,et al, 2002